Endothelial nitric oxide: protector of a healthy mind.

Endothelial nitric oxide (NO) is generated by constitutively active endothelial nitric oxide synthase (eNOS), an essential enzyme responsible for cardiovascular homeostasis. Historically, endothelial NO was first recognized as a major vasodilator involved in control of vasomotor function and local blood flow. In this review, our attention is focused on the emerging role of endothelial NO in linking cerebrovascular function with cognition. We will discuss the recognized ability of endothelial NO to modulate processing of amyloid precursor protein (APP), influence functional status of microglia, and affect cognitive function. Existing evidence suggests that the loss of NO in cultured human cerebrovascular endothelium causes increased expression of APP and β-site APP-cleaving enzyme 1 (BACE1) thereby resulting in increased secretion of amyloid β peptides (Aβ1-40 and Aβ1-42). Furthermore, increased expression of APP and BACE1 as well as increased production of Aβ peptides was detected in the cerebral microvasculature and brain tissue of eNOS-deficient mice. Since Aβ peptides are considered major cytotoxic molecules responsible for the pathogenesis of Alzheimer's disease, these observations support the concept that a loss of endothelial NO might significantly contribute to the initiation and progression of cognitive decline. In addition, genetic inactivation of eNOS causes activation of microglia and promotes a pro-inflammatory phenotype in the brain. Behavioural analysis revealed that eNOS-deficient mice exhibit impaired cognitive performance thereby indicating that selective loss of endothelial NO has a detrimental effect on the function of neuronal cells. Together with findings from prior studies demonstrating the ability of endothelial NO to affect synaptic plasticity, mitochondrial biogenesis, and function of neuronal progenitor cells, it is becoming apparent that the role of endothelial NO in the control of central nervous system function is very complex. We propose that endothelial NO represents the key molecule linking cerebrovascular and neuronal function.

[1]  D. Hinton,et al.  Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology , 2013, Journal of neurochemistry.

[2]  Z. Katušić,et al.  Superoxide anion and endothelial regulation of arterial tone. , 1991, Free radical biology & medicine.

[3]  A. Aguzzi,et al.  Microglia: Scapegoat, Saboteur, or Something Else? , 2013, Science.

[4]  R. Mayeux,et al.  Epidemiology of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[5]  Ping Zhou,et al.  Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein , 2008, Proceedings of the National Academy of Sciences.

[6]  B. Seidel,et al.  Differential expression of neuronal and endothelial nitric oxide synthase in blood vessels of the rat brain , 1997, Neuroscience Letters.

[7]  J. Saczynski,et al.  The Honolulu-Asia Aging Study , 2007 .

[8]  M. Chopp,et al.  Endothelial Nitric Oxide Synthase Regulates Brain-Derived Neurotrophic Factor Expression and Neurogenesis after Stroke in Mice , 2005, The Journal of Neuroscience.

[9]  R. Carare,et al.  Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease , 2009, Alzheimer's Research & Therapy.

[10]  B. Strooper,et al.  The secretases: enzymes with therapeutic potential in Alzheimer disease , 2010, Nature Reviews Neurology.

[11]  J. Provias,et al.  Significant negative correlations between capillary expressed eNOS and Alzheimer lesion burden , 2009, Neuroscience Letters.

[12]  C. Iadecola,et al.  Brain and Circulating Levels of A&bgr;1–40 Differentially Contribute to Vasomotor Dysfunction in the Mouse Brain , 2013, Stroke.

[13]  R. Havlik,et al.  The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. , 1995, JAMA.

[14]  I. T. Demchenko,et al.  Contributions of Endothelial and Neuronal Nitric Oxide Synthases to Cerebrovascular Responses to Hyperoxia , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  D. Geschwind,et al.  Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease , 2009, Nature Medicine.

[16]  J. Garthwaite,et al.  Tonic and Phasic Nitric Oxide Signals in Hippocampal Long-Term Potentiation , 2006, The Journal of Neuroscience.

[17]  C. Iadecola,et al.  Threats to the Mind: Aging, Amyloid, and Hypertension , 2009, Stroke.

[18]  Paul L Huang.  eNOS, metabolic syndrome and cardiovascular disease , 2009, Trends in Endocrinology & Metabolism.

[19]  E. Lo,et al.  Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons , 2008, Proceedings of the National Academy of Sciences.

[20]  A. V. Santhanam,et al.  Endothelial Nitric Oxide Modulates Expression and Processing of Amyloid Precursor Protein , 2010, Circulation research.

[21]  J. Pierce,et al.  Innate immunity receptor CD36 promotes cerebral amyloid angiopathy , 2013, Proceedings of the National Academy of Sciences.

[22]  C. Iadecola,et al.  Hypertension: A Harbinger of Stroke and Dementia , 2013, Hypertension.

[23]  P. Gorelick,et al.  The Dementia of Cardiac Disease , 2012, Current Cardiology Reports.

[24]  J Carter,et al.  Molecular Pathology of Alzheimer's Disease , 2013 .

[25]  R. Carare,et al.  SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease , 2007 .

[26]  E. Clementi,et al.  Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[28]  S. Younkin,et al.  Activation of PPARδ prevents endothelial dysfunction induced by overexpression of amyloid-β precursor protein. , 2012, Cardiovascular research.

[29]  G. V. Van Hoesen,et al.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.

[30]  P. Huang,et al.  Mouse models of nitric oxide synthase deficiency. , 2000, Journal of the American Society of Nephrology : JASN.

[31]  B. Zlokovic,et al.  Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[32]  L. d’Uscio,et al.  Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects. , 2009, Trends in pharmacological sciences.

[33]  P. Vanhoutte,et al.  Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. , 1986, The American journal of physiology.

[34]  S. Younkin,et al.  Activation of PPAR d prevents endothelial dysfunction induced by overexpression of amyloid- b precursor protein , 2012 .

[35]  H. Luhmann,et al.  Impairment of neocortical long-term potentiation in mice deficient of endothelial nitric oxide synthase. , 1999, Journal of neurophysiology.

[36]  F. Heppner,et al.  Microglia as Dynamic and Essential Components of the Amyloid Hypothesis , 2013, Neuron.

[37]  L. d’Uscio,et al.  Supplementation of nitric oxide attenuates AβPP and BACE1 protein in cerebral microcirculation of eNOS-deficient mice. , 2012, Journal of Alzheimer's disease : JAD.

[38]  S. Schulz,et al.  Immunocytochemistry of endothelial nitric oxide synthase in the rat brain: a light and electron microscopical study using the tyramide signal amplification technique. , 1997, Acta histochemica.

[39]  A. Avolio,et al.  Increased tissue transglutaminase activity contributes to central vascular stiffness in eNOS knockout mice. , 2013, American journal of physiology. Heart and circulatory physiology.

[40]  D. Borchelt,et al.  SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein , 1999, Nature Neuroscience.

[41]  C. Iadecola.  Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[42]  T. Wyss-Coray,et al.  Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. , 2012, Cold Spring Harbor perspectives in medicine.

[43]  D. Attwell,et al.  Assessing the physiological concentration and targets of nitric oxide in brain tissue , 2008, The Journal of physiology.

[44]  J. Beckman.  Understanding peroxynitrite biochemistry and its potential for treating human diseases. , 2009, Archives of biochemistry and biophysics.

[45]  H. Haas,et al.  Cortico-striatal synaptic plasticity in endothelial nitric oxide synthase deficient mice , 2003, Brain Research.

[46]  A. Nappi,et al.  Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .

[47]  D. Atochin,et al.  Endothelial nitric oxide synthase transgenic models of endothelial dysfunction , 2010, Pflügers Archiv - European Journal of Physiology.

[48]  S. Snyder,et al.  Species, strain and developmental variations in hippocampal neuronal and endothelial nitric oxide synthase clarify discrepancies in nitric oxide-dependent synaptic plasticity , 2003, Neuroscience.

[49]  John Garthwaite,et al.  On the Role of Nitric Oxide in Hippocampal Long-Term Potentiation , 2003, The Journal of Neuroscience.

[50]  Emilio Clementi,et al.  Calorie Restriction Promotes Mitochondrial Biogenesis by Inducing the Expression of eNOS , 2005, Science.

[51]  G. Pawlik,et al.  Quantitative capillary topography and blood flow in the cerebral cortex of cats: an in vivo microscopic study , 1981, Brain Research.

[52]  Edith Hamel,et al.  Neurovascular function in Alzheimer's disease patients and experimental models , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[53]  C. Heeschen,et al.  Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells , 2003, Nature Medicine.

[54]  B. Cha,et al.  Metabolic Syndrome and Cardiovascular Disease , 2003 .

[55]  E. Clementi,et al.  Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric Oxide , 2003, Science.

[56]  George A. Carlson,et al.  Exogenous Aβ1–40 Reproduces Cerebrovascular Alterations Resulting from Amyloid Precursor Protein Overexpression in Mice , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.